评估结论指出，如果研制不出有效的新药，到2050年可能导致上千万人死于与抗菌素耐药性相关的疾病，并造成高达一百万亿美元的损失。
As the Review concluded, failure to create effective new drugs could result in ten million people dying from AMR-related diseases every year by 2050, at a cost of some $100 trillion.